All Immunology articles – Page 9
-
NewsResearchers find a common weakness in major gut pathogens
The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children. A shared biological feature of these gut pathogens could lead to a vaccine that protects against both.
-
NewsA new HIV vaccine study reveals new hope—and new challenges—for aging patients
A new clinical trial demonstrates that novel vaccines can significantly boost T cells targeting and could contribute to curative approaches against HIV.
-
NewsYoung frogs “play it safe” when disease strikes
New research shows that young frogs prioritize growing quickly even when infected with a deadly pathogen, shifting energy toward immune defense only when infections become severe.
-
NewsResearcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes
University of California, Irvine immunologist Lbachir BenMohamed has been awarded a $3.93 million National Institutes of Health grant to develop and test a novel therapeutic vaccine designed to prevent recurrent genital herpes.
-
NewsTherapeutic vaccine shows mixed efficacy in preventing head and neck cancer recurrence
Researchers explore the effectivity of new therapeutic cancer vaccine in preventing the recurence of human papillomavirus triggered cancers.
-
NewsStudy reveals how bacteria assemble their envelope
Researchers have discovered a key process for how the outer membrane of gram-negative bacteria attaches to the cell wall, advancing the understanding of how these bacteria frequently manifest resistance to antibiotics.
-
NewsSingle amino acid change may help viruses jump from bat to human
New research reports that a single amino-acid change alters how a coronavirus protein interacts with the human and bat immune systems, shifting the body’s response to infection.
-
NewsPathogens survive conditions on extraterrestrial locations
Microorganisms from our planet could survive on celestial bodies where water is present, such as Mars, reveals a study focusing on simulated space conditions. Our immune system reacts less effectively to pathogens that have undergone such a simulated space journey.
-
NewsShingles vaccine linked to lower dementia risk in older adults, study suggests
A target trial emulation of older adults entering skilled-nursing facilities found that those who received the recombinant shingles vaccine (RZV) had a lower risk of developing dementia over the following four years compared with those who were not vaccinated.
-
NewsmRNA flu vaccine offers immune protection against wide array of influenza virus strains
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
-
NewsA gut bacteria molecule may calm intestinal inflammation by turning down cellular energy
A new study suggests enterobactin, a molecule produced by gut bacteria, could offer a new pathway for treating inflammatory bowel disease.
-
NewsHow exercise fights implant infections: Muscle hormone “musclin” unveiled as a key defender
A new study reveals how the exercise-induced myokine musclin reprograms macrophage metabolism to clear dead cells and treat periprosthetic joint infections.
-
NewsGut bacteria linked to osteoporosis risk in primary hyperparathyroidism
Researchers studying primary hyperparathyroidism, a common endocrine disorder characterized by excessive secretion of parathyroid hormone, have identified Bifidobacterium longum as a potential microbial driver of bone loss through immune-mediated mechanisms.
-
NewsScientists track breakthrough single-dose vaccines for Andes hantavirus strain
Researchers report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus after a single dose. They are working to fast-track these single-dose vaccines into human clinical trials.
-
NewsAntibody clues could improve long Covid care and prognosis
Researchers have found that SARS-CoV-2 antibody patterns may help assess infection history, symptom severity, and cognitive complications in long Covid.
-
NewsResearchers investigate the underlying causes of post-treatment Lyme disease syndrome
With an estimated one million Americans afflicted with post-treatment Lyme disease syndrome, newly funded research seeks to determine whether the condition is triggered by a persistent autoimmune response, and if a test can be devised to pinpoint who is more likely to develop it.
-
NewsThousands of young people to be offered two-dose MenB vaccine ahead of autumn
Thousands of young people across England will get protection against meningococcal B disease (MenB) through a one-off vaccination programme launching ahead of the 2026 academic year.
-
NewsLouse-borne relapsing fever: How the pathogen evades the immune system
A research team has now identified and characterized five closely related proteins that are crucial for the survival of Borrelia recurrentis in the human body. These so-called Chi proteins appear to have evolved from a common ancestor and are therefore considered homologous.
-
NewsFasting-mimicking diet reduces gum disease inflammation
A new study highlights how lifestyle modifications could be important alongside plaque control in managing gum disease. While fasting has been linked to reduced inflammation around the body, this is the first to establish a relationship with gum disease too.
-
NewsFrom pest to useful tool: How wax moth larvae can help reduce animal testing in research
A new study indicates greater wax moth larvae show great potential as a robust and ethically acceptable in vivo model for studying pathogenic bacteria.